Abstract Details

Title Should Primary Multiple Sclerosis Treatment Regimen Be Changed after a Relapse?

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 193

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
	No disclosure on file

��ɫ����